EZH-102: A Phase 1 Study of the EZH2 Inhibitor Tazemetostat in Pediatric Subjects with Relapsed or Refractory INI1-Negative Tumors or Synovial Sarcoma

  • Goldman, Stewart (PD/PI)

Project: Research project

Project Details

StatusActive
Effective start/end date7/1/168/31/50

Funding

  • Epizyme, Inc.
  • Epizyme, Inc.